The presence of iridescent particles in the anterior chamber is well recognised in phacolytic glaucoma where a high rise in intraocular pressure occurs in response to leakage of material from a hypermature cataract.`17 These particles have been considered to be cholesterol crystals by some authors'2468 and this has recently been verified.9"0 Similar particles occur around the lens nucleus in hypermature cataracts and have been thought to be calcium oxalate by some workers.5"' It is important for our understanding of the relation between phacolytic glaucoma and hypermature cataract to establish whether the crystals around the nucleus are cholesterol or oxalate. Recently we have been able to examine these crystals in aspirate ofthe liquefied cortex of a hypermature cataract.
Case report A male patient, aged 77 years, presented to us with a hypermature cataract. He had previously undergone bilateral trabeculectomies for bilateral cyclitic glaucoma uncontrolled by topical medication. The right eye subsequently needed reoperation with needling of the bleb and later repair of the bleb. On slit-lamp examination the dense nucleus of the lens was displaced downward and liquefied cortex with brilliant iridescent particles was seen within the lens capsule above the nucleus (Fig IA) . The iridescent particles were demonstrated within the lens on specular microscopy with a morphology strongly suggestive of cholesterol crystals (Fig 1B) . During a right extracapsular extraction some of the liquefied cortex was aspirated and a sample of aqueous was also obtained. Subsequently the eye settled satisfactorily but a total retinal detachment was present with preretinal proliferation and retraction.
Pathological investigation Wet mounts of the fluid obtained by anterior chamber paracentesis showed no cells or crystals. The liquefied lens cortex contained numerous flat, rhomboidal crystals, many of which were notched at the corner or were L-shaped (Fig 2) , but there were no inflammatory cells. The morphology of the crystals was characteristic of cholesterol or cholesterol ester crystals, and this was confirmed by semiquantitative thin layer chromatography (TLC) using a solvent system designed for cholesterol and its esters. This showed a large spot with correct mobility for unesterified cholesterol, a barely visible spot for esters, and a barely visible spot with mobility compatible with phospholipid. Quantitative in vitro assay showed unesterified cholesterol 0-38 ,tmol in the thawed assay sample with estimated concentration of 1900 jtmol/l (estimated sample volume 0-2 ml) and assay detection limit of 400 ,umol/l. Esters of cholesterol and phospholipid were below the assay sensitivity limit. This quantitative analysis guarantees that at least 75% to 80% of the sample consists of unesterified cholesterol, the 'proved' percentage. The TLC results indicate that the correct figure is much higher, perhaps 99% or more, but this depends on visual inspection and is only semiquantitative. The 'proved' upper limit on the percentage figure is limited only because the sensitivity limit of the quantitative assay is being approached, not because these two tests differ in their results. The small amount of phospholipid present is compatible with diffusion into the lens, or origin from breakdown of lens fibre plasma membranes within the lens. The latter seems more likely. Other 
